SCHEMBL4864537

SCHEMBL4864537

CCNC(=O)N(Cc1cccc(N)c1)N(CC)C(=O)NCc1cccc([N+](=O)[O-])c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
CYP1A2 P05177 1/20 0.46
PTPN1 P18031 3/20 0.43
OPRM1 P35372 1/20 0.43
OPRK1 P41145 1/20 0.43
ALDH1A1 P00352 3/20 0.41
ACKR3 P25106 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
RECQL P46063 1/20 0.40
BAZ1A Q9NRL2 1/20 0.40
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.39
PYCR1 P32322 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4864527 0.82 PTPN1 (0.60) CYP2D6CYP2C9CYP2C19PTPN1OPRM1
SCHEMBL4865816 0.77 ALDH1A1 (0.53) CYP2D6CYP2C9CYP2C19CYP1A2ALDH1A1
SCHEMBL11628064 0.75 PTPN1 (0.53) PTPN1OPRM1OPRK1ALDH1A1ACKR3
SCHEMBL4865028 0.74 PTPN1 (0.68) CYP2D6CYP2C9CYP2C19CYP1A2PTPN1
Hydrochloric Acid SCHEMBL4862375 0.73 PTPN1 (0.51) CYP2D6CYP2C9CYP2C19CYP1A2PTPN1
SCHEMBL13623008 0.72 ALDH1A1 (0.63) CYP1A2ALDH1A1MEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL1025685 0.72 ALDH1A1 (0.61) CYP1A2ALDH1A1MEN1KMT2AMAPT
SCHEMBL4865811 0.71 NAMPT (0.65) PTPN1OPRM1OPRK1ALDH1A1ACKR3
SCHEMBL4582840 0.71 PTPN1 (0.63) CYP2D6CYP2C9CYP2C19CYP1A2PTPN1
Hydrochloric Acid SCHEMBL4862364 0.71 PTPN1 (0.60) CYP2D6CYP2C9CYP2C19CYP1A2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7384963-B2 2′-Methyl-5-(1,3,4-oxadiazol-2-yl)1, 1′-biphenyl-4-carboxaide derivatives and their use as p38 kinase GLAXO GROUP LIMITED (GB) 2008-06-10 US disclosed